Amcor plc announced on April 30, 2025, the successful completion of its all-stock combination with Berry Global, effective today. This merger significantly enhances Amcor's position as a global leader in consumer and healthcare packaging solutions, leveraging unique material science and innovation capabilities.
The combined entity is expected to deliver approximately $260 million of pre-tax synergies in fiscal year 2026, driving an adjusted EPS accretion of approximately 12 percent. By the end of fiscal year 2028, total pre-tax synergy benefits are projected to build to approximately $650 million, alongside an additional $280 million in one-time cash benefits from working capital improvements.
Amcor anticipates annual cash flow to exceed $3 billion by fiscal year 2028, providing substantial capacity for organic reinvestment, value-accretive M&A, and shareholder returns through dividends and share repurchases. This combination is expected to unlock further opportunities to refine the portfolio and enhance average growth rates, margins, and cash generation.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.